AbbVie Common Stock (1ABBV) Stock Price & News

AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia

About AbbVie Common Stock

CEORobert A. Michael

Employees57K

FoundedApr 10, 2012

HeadquartersNorth Chicago, Illinois, United States

SectorBiotechnology

Websiteabbvie.com

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	15.78B	16.62B	15.00B	16.99B
Cost of goods sold	4.46B	4.55B	4.22B	4.29B
Cost of revenue	4.46B	4.55B	4.22B	4.29B
Research and development expenses	2.29B	2.58B	2.47B	2.34B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.43B	3.82B	3.49B	3.63B
Operating expense	5.72B	6.40B	5.96B	5.98B
Total operating expenses	10.18B	10.95B	10.18B	10.27B
Operating income	5.60B	5.67B	4.82B	6.72B
Other non operating income	199.00M	120.00M	-21.00M	43.00M
EBT including unusual items	714.00M	2.67B	1.04B	4.28B
EBT excluding unusual items	5.11B	5.12B	4.17B	6.09B
Income tax expense	526.00M	853.00M	342.00M	662.00M
Effective tax rate	73.67%	31.97%	32.92%	15.47%
Other operating expenses	-	-	-	-
Net income	186.00M	1.82B	695.00M	3.61B
Net profit margin	1.18%	10.93%	4.63%	21.27%
Earnings per share	1.86	2.71	2.65	3.65
Interest and investment income	72.00M	59.00M	72.00M	-
Interest expense	-739.00M	-714.00M	-717.00M	-679.00M
Net interest expenses	-667.00M	-655.00M	-645.00M	-679.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	7.66B	7.66B	6.76B	8.66B
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research